ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,222, issued on Sept. 9, was assigned to VIB VZW (Ghent, Belgium), Universiteit Gent (Ghent, Belgium), Centre National De Le Recherche Scientifque (Paris), Universite De Montpellier (Montpellier, France) and Centre Hospitalier Regional Universitaire de Montpellier (Montpellier, France).

"Fusokines involving cytokines with strongly reduced receptor binding affinities" was invented by Jan Tavernier (Balegem, Belgium), Jennyfer Bultinck (Ledeberg, Belgium), Sarah Gerlo (Ghent, Belgium), Gilles Uze (Montpellier, France), Franciane Paul (Montpellier, France) and Yann Bordat (Montpellier, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present i...